Ashley Gallagher

The label includes postmarking reports showing rare instances of pulmonary aspiration for patients undergoing procedures that require general anesthesia or deep sedation.

The disorder presents as severe lung disease, with lung transplantation as the only current therapeutic option for long-term survival.

Increased global capacity for surveillance could help monitor seasonal influenza to reduce the risk of vaccine mismatch and inform effective interventions.

This marks the first and only therapy to receive this designation for Sjögren disease, which currently has no approved treatment.

Bimekizumab-bkzx is the first and only approved medication that targets both interleukin (IL) 17F and IL-17A.

Data from the BROADEN and PROGRESS studies were presented at the International Papillomavirus Conference 2024 in Edinburgh, UK, from November 12 to 15.

Investigators also established a negative association with higher vitamin C intake and diabetes prevalence.

There were 2 main types of switches, including switching to rituximab subcutaneous and switching among different intravenous rituximab treatments.

Familial chylomicronemia syndrome (FCS) currently has no FDA-approved treatment and is associated with an increased risk of acute pancreatitis.

Children with obesity, asthma, and gastrointestinal disease had longer durations of stays compared with children without comorbidities.